Celsion Corp (CLSN)

0.96 -0.05  -4.95% NASDAQ Oct 20, 12:48 USD
View Full Chart
Price Chart
View All CLSN News

News

View All Events

Events

Date Type Description
11/16/2021 Earnings Results Q3 2021 Earnings Results
11/16/2021 11:00 EST Earnings Calls Q3 2021 Earnings Call
08/12/2021 Earnings Results Q2 2021 Earnings Results
08/12/2021 11:00 EST Earnings Calls Q2 2021 Earnings Call
06/04/2021 10:00 EST AGM 2020 Annual General Meeting
05/14/2021 Earnings Results Q1 2021 Earnings Results
05/14/2021 10:00 EST Earnings Calls Q1 2021 Earnings Call
03/19/2021 Earnings Results Q4 2020 Earnings Results
03/19/2021 11:00 EST Earnings Calls Q4 2020 Earnings Call
11/16/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Celsion Corp is active in the biotechnology sector. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in a clinical trial for the treatment of primary liver cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.
  • URL: https://www.celsion.com
  • Investor Relations URL: http://investor.celsion.com/
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Nov. 16, 2021
  • Last Earnings Release: Aug. 12, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.